Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • purpurbaer
    Junior Member
    • Mar 2015
    • 1

    #1

    Mitochondrial genes partially not expressed

    Dear all,

    I have recently started working with RNA-seq data. I am looking at protein-coding genes in fat, liver, heart and skeletal muscle tissue in mice. While exploring my data, I noticed that a stretch of the mitochondrial genome seems to be not expressed in any of my samples. It is the stretch that covers genes from COX2 (ENSMUSG00000064354) to ND4L (ENSMUSG00000065947), all on the heavy strand. All protein coding genes including the tRNAs give me zero reads. We know, however, for certain that the gene products should be there, since we made independent protein measurements of genes along the stretch. And mice without all these genes expressed, wouldn't be viable. The reference genome we use for alignment also shows, that there should be genes there.

    The other mitochondrial genes show a very high level of expression (above 1000 RPKM).

    Then we looked at other datasets, that we have obtained from collaborators and previous experiments. The data was gathered by different researchers and in different labs, using different types of RNA enrichment (ribozero and poly-A enrichment), different species (mouse and human), and at different times. We see the same pattern to a more or less same extend in all the samples!
    I was wondering, whether anybody has observed that before or could come up with a reason for what's going on?

    Ideas are much appreciated
  • mziemann
    Member
    • Aug 2010
    • 10

    #2
    If those genes have exact copies elsewhere in the nuclear genome, the reads may not be uniquely placed, meaning that they might be omitted depending on your pipeline. Check the mappability of those regions on the UCSC browser for your read-length.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    35 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    41 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    45 views
    0 reactions
    Last Post SEQadmin2  
    Working...